Patents Assigned to GE Healthcare Bio-Sciences AB
  • Patent number: 9035661
    Abstract: A flow-through conductivity sensor assembly comprises a housing (4) having a flow passage with an inlet end and an outlet end. The cross section of at least a section of the flow passage extension between the inlet and outlet ends is divided into a conductivity measuring channel (2) and a parallel by-pass channel (3) of larger cross-sectional area than the measuring channel (2).
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: May 19, 2015
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Lars Andersson, Stefan D'Argy, Patric Fricking, Joachim Tollstoy
  • Patent number: 8999157
    Abstract: The present invention is relates to method for production of a biomolecule adsorbent with a pentadentate ligand with very strong chelating properties, and to methods for use thereof for, for example, protein purification, detection or binding. The biomolecule adsorbent comprises the formula: wherein Q is a carrier, S is a spacer, L is an amide linkage, X is COOH, and n=2 or 3.
    Type: Grant
    Filed: July 7, 2008
    Date of Patent: April 7, 2015
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Lars C. Andersson, Anna Arefalk, Ola Lind, Bjorn Noren
  • Publication number: 20150080554
    Abstract: The invention discloses an immunoglobulin-binding protein comprising one or more mutated immunoglobulin-binding domains (monomers) of staphylococcal Protein A (E, D, A, B, C) or protein Z or a functional variant thereof, wherein in at least one of the one or more mutated monomers, the asparagine or histidine at the position corresponding to H18 of the B domain of Protein A or of Protein Z has been deleted or substituted with a first amino acid residue which is not proline or asparagine and wherein, if the amino acid residue at position 57 is proline and the amino acid residue at position 28 is asparagine, then the amino acid residue at the position corresponding to H18 of the B domain of protein A or of protein Z is not serine, threonine or lysine.
    Type: Application
    Filed: March 26, 2013
    Publication date: March 19, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Mats Ander, Goran Bauren, Tomas Bjorkman, Per-Mikael Aberg, Gustav Rodrigo
  • Publication number: 20150073128
    Abstract: The present invention relates to a chromatography ligand defined by the following formula R1—R2—N(R3)—R4—R5 wherein R1 is a substituted or non-substituted phenyl group; R2 is a hydrocarbon chain comprising 0-4 carbon atoms; R3 is a hydrocarbon chain comprising 1-3 carbon atoms; R4 is a hydrocarbon chain comprising 1-5 carbon atoms; and R5 is OH or H. The invention also comprises a separation matrix, comprising the described ligands coupled to a porous support, such as particles or a membrane. The ligand and matrix according to the invention is useful for purification of biomolecules or organic compounds, such as proteins, polypeptides, DNA etc. An advantageous use according to the invention is the purification of antibodies.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 12, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: CARINA ENGSTRAND, ANNIKA FORSS, GUNNAR GLAD, BO-LENNART JOHANSSON, HANS J JOHANSSON, JEAN-LUC MALOISEL
  • Publication number: 20150061282
    Abstract: The invention relates to a An aseptic connector comprising a first connection unit (102; 202; 302; 402; 502) provided with a first terminal end surface (104; 204; 304; 404; 504) and a second connection unit (106; 206; 306; 406; 506) provided with a second terminal end surface (108; 208; 308; 408; 508); said first and second terminal end surfaces are each provided with at least one first and second opening (110, 112; 210, 212; 310, 312; 410, 412; 510, 512), which openings are orientated to substantially coincide when said first and second connection units are connected to each other; said first and second openings are sealed by at least one film (114; 214; 314; 414; 514) arranged on said first and second connection units, so that the contact between the film and each connection unit is aseptic; said at least one film is adapted to be mated with a corresponding film on the other connection unit when said first and second connection units are connected to each other; and said mated films are adapted to be pulled
    Type: Application
    Filed: March 25, 2013
    Publication date: March 5, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Eric Faldt, Klaus Gebauer
  • Publication number: 20150056694
    Abstract: The invention relates to a bag locking mechanism comprising, a fixed locking means (106), provided with a first abutment surface (116), a movable locking means (108; 208), which is movable between a locking position and a releasing position, and a second abutment surface (118; 218) arranged on the movable locking means (108; 208). The fixed locking means (106) defines by its configuration, at least partly a restricted locking space (114), in which the movable locking means (108; 208) is movable between the locking and releasing position.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 26, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Patrik Akerstrom
  • Publication number: 20150041009
    Abstract: The present invention relates to a device (1) for delivery of fluid, said device comprising at least two fluid ducts (12-17) of flexible material, each of which in one end can be connected to a fluid source and in the opposite end is connected to a manifold (18) having an inlet end and an outlet end, each of said fluid ducts (12-17) comprising a pinch valve (19) for closing and opening the duct. According to the invention a check valve (20) is disposed in at least one of said fluid ducts (12-17) in the end thereof connected to the manifold (18).
    Type: Application
    Filed: March 28, 2013
    Publication date: February 12, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Klaus Gebauer, Ekta Mahajan, Eric Faldt
  • Publication number: 20150037873
    Abstract: The present invention relates to a method for endotoxin removal from a sample comprising the following steps: combining the sample comprising one or more target molecule(s) with a chromatography media comprising beads having an inner porous core functionalized with ligands capable of binding endotoxin and an outer porous layer without functional groups and a pore size small enough to exclude the target molecule from the inner core; and collecting the sample from the media, wherein the sample comprises an endotoxin level which is at least 75% less, preferably 90% less, than before the removal and the yield of the target molecule is at least 75%.
    Type: Application
    Filed: February 27, 2013
    Publication date: February 5, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Patrik Adielsson, Tobias E. Soderman, Anna Akerblom
  • Publication number: 20150029815
    Abstract: The present invention relates to a mixing system comprising a vessel (1) for housing a disposable fluid mixing bag (2), which vessel (1) comprises a base (3) supporting the fluid mixing bag (2) and a sidewall (4) extending vertically upwards from the base (3). The sidewall (4) of the vessel comprises a door opening (5) which is closable by a sliding door (6). The system with the sliding door provides an easy access to the inside of the vessel (1) in a space saving manner.
    Type: Application
    Filed: March 14, 2013
    Publication date: January 29, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Klaus Gebauer, Patrick Jonsson, David Ronnholm
  • Publication number: 20150001775
    Abstract: The present invention relates to methods for conducting maintenance on chromatography columns used in industrial-scale chromatography. In particular, the invention is concerned with safer methods for performing maintenance on such columns, such as cleaning and replacing bed supports, distributors, nozzles, O-rings and other column components, by the use of a handling device to support, lift, carry and manipulate such column components.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: JOHN DAVIS, STEFAN KJELL ERIKSSON
  • Patent number: 8921120
    Abstract: A method of determining multimers of a macromolecule monomer in a sample containing the macromolecule comprises the steps of (i) determining the total concentration of macromolecule in the sample, (ii) determining by a biosensor-based detection method, especially mass-sensing, the active concentration of macromolecule in the sample, wherein physical characteristics of the macromolecule monomer are used, (iii) comparing the relationship of determined active macromolecule concentration to total macromolecule concentration for the sample with a corresponding relationship for an at least substantially multimer-free macromolecule-containing sample, and (iv) from a resulting difference determining the presence of multimers in the sample. The method may be used in the purification of macromolecules, such as proteins.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: December 30, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Ewa Pol
  • Patent number: 8915141
    Abstract: Pressure sensor unit for sealed attachment to a fluidic system comprising a mounting member, a membrane cavity extending through the mounting member with an opening in contact with the fluidic system when the sensor unit is attached thereto, a membrane formed at the distal end of the membrane cavity, and a membrane deflection sensor, wherein the membrane is separated from the mounting member by a stress insulating member arranged to isolate the membrane from stress and strain in the mounting member.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: December 23, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Tomas Agren, Klas Marteleur
  • Publication number: 20140353224
    Abstract: Automated fluid handling system comprising a housing and two or more fluid handling units arranged as interchangeable modular components with an external fluidics section and an internal non fluidics section, and wherein the housing comprises a liquid handling panel with two or more of component positions for receiving said interchangeable modular components such that the external fluidics section is separated from the non fluidics section by the liquid handling panel.
    Type: Application
    Filed: August 19, 2014
    Publication date: December 4, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: JOHAN BLOMBERG, MATS LUNDKVIST
  • Patent number: 8895710
    Abstract: The present invention relates to a chromatography ligand defined by the following formula R1—R2—N(R3)—R4—R5 wherein R1 is a substituted or non-substituted phenyl group; R2 is a hydrocarbon chain comprising 0-4 carbon atoms; R3 is a hydrocarbon chain comprising 1-3 carbon atoms; R4 is a hydrocarbon chain comprising 1-5 carbon atoms; and R5 is OH or H. The invention also comprises a separation matrix, comprising the described ligands coupled to a porous support, such as particles or a membrane. The ligand and matrix according to the invention is useful for purification of biomolecules or organic compounds, such as proteins, polypeptides, DNA etc. An advantageous use according to the invention is the purification of antibodies.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: November 25, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Carina Engstrand, Annika Forss, Gunnar Glad, Bo-Lennart Johansson, Hans J. Johansson, Jean-Luc Maloisel
  • Publication number: 20140343253
    Abstract: There is a recognized need for novel, more simplified, approaches to isolation of plasma from whole blood, as well as a need to isolate cell-free plasma fractions containing different plasma proteins. Methods are divulged for use of aqueous phase systems, formed in blood or blood containing solutions via addition of a single polymer at relatively low concentration, to effect isolation (clarification) of plasma proteins from blood cells. Methods are also divulged to replace widely used Cohn-type plasma protein fractionation which is based on sequential addition of up to 40% (v/v) ethanol and other precipitants, with simple sequential addition of a polyacid. The latter results in isolation of plasma protein fractions (i.e. fibrinogen, immunoglobulin, albumin) in sequence similar to that obtained with Cohn Fractionation and therefore may be suitable for use to reduce solvent use and solvent-related process complications in existing plasma protein purification processes.
    Type: Application
    Filed: September 14, 2012
    Publication date: November 20, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: James Van Alstine, Mikael Berg, Johanna Kjorning, JAMIL Shanagar
  • Publication number: 20140338527
    Abstract: Disclosed is piston pump (10) and piston assembly (30) for such a pump. The piston pump includes a cylinder (20) having an inner wall surface (22) formed around an axis A of the cylinder, and a piston assembly (30) for sliding along said cylinder axis, said piston assembly includes a slideable flexible seal (34) in generally sealing contact with said inner wall surface, and a seal mounting (44), said seal mounting having a plurality of circumferentially arranged members (37) moveable radially of said axis to increase or decrease the size of the seal.
    Type: Application
    Filed: September 27, 2012
    Publication date: November 20, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventor: Mats Lundkvist
  • Publication number: 20140329995
    Abstract: The invention discloses a polypeptide capable of binding immunoglobulins or immunoglobulin-containing proteins, which polypeptide comprises six or more domains of protein Z or the C domain of protein A or a functional variant thereof. It also discloses separation matrices comprising the polypeptide and methods of using the separation matrices for separation of immunoglobulins or immunoglobulin-containing proteins.
    Type: Application
    Filed: November 28, 2012
    Publication date: November 6, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Hans J. Johansson, Ronnie Palmgren
  • Publication number: 20140322826
    Abstract: The present invention relates to a method for detection of binding or interaction events between a binding agent and its corresponding analyte (such as an antibody and an antigen) in which a signal is detected which is substantially more amplified and thus easier to detect than in prior art systems. The method comprises simultaneous but separate addition of a first enhancement reagent having affinity for said analyte and a second enhancement reagent having affinity for the first enhancement reagent wherein the first enhancement reagent binds to the analyte and the second enhancement reagent binds to the first enhancement reagent, and, wherein the first and second enhancement reagents have more than one binding site so that they are able to bind to each other to thereby amplify a detectable signal from the binding event.
    Type: Application
    Filed: December 21, 2012
    Publication date: October 30, 2014
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Tanja Jarhede, Anita Larsson
  • Patent number: 8864997
    Abstract: The present invention relates to methods for conducting maintenance on chromatography columns used in industrial-scale chromatography. In particular, the invention is concerned with safer methods for performing maintenance on such columns, such as cleaning and replacing bed supports, distributors, nozzles, O-rings and other column components, by the use of a handling device to support, lift, carry and manipulate such column components.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: October 21, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: John Davis, Stefan K. Eriksson
  • Patent number: D715957
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: October 21, 2014
    Assignee: GE Healthcare Bio-Sciences AB
    Inventor: Per Uselius